Paper
Document
Submit new version
Download
Flag content
0

Inflammatory Biomarkers Predict Response and Survival in Chemotherapy-Ineligible and Untreated Acute Myeloid Leukemia Patients Receiving Venetoclax-Azacytidine As Front-Line Therapy

0
TipTip
Save
Document
Submit new version
Download
Flag content

Abstract

Add an abstract to this paper

Help us improve the quality of this page by adding an abstract.

Paper PDF

This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.